Abstract
A number of chlorine-, bromine- and fluorine-containing organic molecules cause nephrotoxicity in experimental animals and in some cases in man. Many of these chemicals are used as industrial solvents, chemical intermediates or pesticides, while others have had a more direct clinical application as anticancer chemotherapeutic agents or anaesthetics. Several reviews on the effect of these chemicals on the kidney are available1–5. This chapter will therefore not discuss all halogenated chemicals which produce renal necrosis, but instead will review selected examples of the types of mechanism(s) whereby halogenated chemicals can be activated by renal tissue and thereby cause toxicity.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Maher, J.F., Toxic nephropathy, in The Kidney, Brenner, B.M. and Rector, F.C. Jr., Eds., Saunders, Philadelphia, 1976, 1355.
Kluwe, W.M., The nephrotoxicity of low molecular weight halogenated alkane solvents, pesticides and chemical intermediates, in Toxicology of the Kidney, Hook, J.B., Ed., Raven Press, New York, 1981, 179.
Hook, J.B., McCormack, K.M. and Kluwe, W.M., Biochemical mechanisms of nephrotoxicity, in Reviews in Biochemical Toxicology, Vol. 1, Hodgson, E., Bend, J.R. and Philpot, R.M., Eds., Elsevier, New York, 1979, 53.
Lock, E.A., Renal necrosis produced by halogenated chemicals, in Nephrotoxicity: Assessment and Pathogenesis, Bach, P.H., Bonner, F.W., Bridges, J.W. and Lock, E.A., Eds., J. Wiley, Chichester, 1982, 396.
Rush, G.F., Smith, J.H., Newton, J.F. and Hook, J.B., Chemically induced nephrotoxicity: role of metabolic activation, CRC Crit. Rev. Toxicol., 13, 99, 1984.
Tisher C.A., Anatomy of the kidney, in The Kidney, Brenner, B.M. and Rector F.C. Jr., Eds., Saunders, Philadelphia, 1976, 3.
Venkatchalam, M.A., Bernard D.B., Donohoe, J.F. and Levinsky, N.G., Ischemic damage and repair in the rat proximal tubule: differences among the Sp S2 and S3 segments, Kidney Int., 14, 31, 1978.
Valtin, H., Renal Function: mechanisms preserving fluid and solute balance in health, Little, Brown, Boston, 1973.
Hook, J.B., Mechanisms of renal toxicity, in Organ-Directed Toxicity - Chemical Indices and Mechanisms, Brown, S.S. and Davies, D.S., Eds., Per- gamon Press, Oxford, 1981, 45.
Litterst, C.L., Mimnaugh, E.G., Reagan, R.L. and Gram, T.E., Comparison of in vitro drug metabolism by lung, liver and kidney of several common laboratory species, Drug. Metab. Dispos., 3, 259, 1975.
Litterst, C.L., Mimnaugh, E.G., and Gram, T.E., Comparative alterations in extrahepatic drug metabolism by factors known to affect hepatic activity, Biochem. Pharmacol., 26, 749, 1977.
Fry, J.R., Wiebkin, P., Kao, J., Jones, C.A., Gwynn, J. and Bridges, J.W., A comparison of drug-metabolising capability in isolated viable rat hepatocytes and renal tubule fragments, Xenobiotica, 8, 113, 1978.
Magee, P.N. and Barnes, J.M., Carcinogenic nitroso compounds, Adv. Cancer Res., 10, 163, 1967.
Swann, P.F. and McLean, A.E.M., Cellular injury and carcinogenesi; The effect of a protein-free high-carbohydrate diet on the metabolism of dimethyl- nitrosamine in the rat, Biochem. J., 124, 283, 1971.
Gillette, J.R., A perspective on the role of chemically reactive metabolites of foreign compounds in toxicity. I. Correlation of changes in covalent binding of reactive metabolites with changes in incidence and severity of toxicity, Biochem. Pharmacol., 23, 2785, 1974.
Gillette, J.R., A perspective on the role of chemically reactive metabolites of foreign compounds in toxicity. II. Alterations in the kinetics of covalent binding, Biochem. Pharmacol., 23, 2427, 1974.
Bonse, G. and Henschler, D., Chemical reactivity, biotransformation and toxicity of polychlorinated aliphatic compounds, CRC Crit. Rev. Toxicol., 4, 395, 1976.
Nelson, S.D., Boyd, J.R. and Mitchell, J.R., Role of metabolic activation in chemical-induced tissue injury, in Drug Metabolism Concepts, Jerina, D.M., Ed., American Chemical Society, Washington DC, 1977, Chap. 8.
Gillette, J.R., Mitchell, J.R. and Brodie, B.B., Biochemical mechanisms of drug toxicity, Ann. Rev. Pharmacol., 14, 271, 1974.
Jones, D.P., Orrenius, S. and Jakobsson, S.W., Cytochrome P-450 linked monooxygenase system in kidney, in Extrahepatic Metabolism of Drugs and other Foreign Compounds, Gram, T.E., Ed., SP Medical and Scientific Books, New York, 1980, 123.
Lake, B.G., Hopkins, R., Chakaborty, J., Bridges, J.W. and Parke, D.V., The influence of some hepatic enzyme inducers and inhibitors on extrahepatic drug metabolism, Drug Metab. Dispos., 1, 342, 1973.
Hook, G.E.R., Haseman, J.K. and Lucier, J.W., Induction and suppression of hepatic and extrahepatic microsomal foreign compound-metabolising enzyme systems by 2,3,7,8-tetrachlorodibenzo-p-dioxin, Chem.-Biol. Interact., 10, 199, 1975.
Hook, J.B., Elcombe, C.R., Rose, M.S. and Lock E.A., Characterisation of the effects of known hepatic monooxygenase inducers on male and female rat and mouse kidneys, Life Sci., 31, 1077, 1982.
McCormack, K.M., Kluwe, W.M., Rickert, D.E., Sanger, V.L. and Hook, J.B., Renal and hepatic microsomal enzyme stimulation and renal function following three months of dietary exposure to polybrominated biphenyls, Toxicol. Appi. Pharmacol., 44, 539, 1978.
Kluwe, W.M. and Hook, J.B., Comparative induction of xenobiotic metabolism in rodent kidney, testis and liver by commercial mixtures of polybrominated biphenyls and polychlorinated biphenyls, phenobarbital and 3- methylcholanthrene: absolute and temporal effects, Toxicology, 20, 259, 1981.
Lock, E.A., Stonard, M.D. and Elcombe, C.R, The induction of w and p- oxidation of fatty acids and a2u-globulin in the liver and kidney of rats administered 2,2,4-trimethylpentane, Xenobiotica, 17, 513, 1987.
Uehleke, H. and Griem, H., Stimulierung des oxydation von Fremdstoffen in nierenmikdrosomen durch phenobarbital, Naunyn-Schmiedebergs Arch. Pharmakol. Exp. Pathol., 261, 151, 1968.
Kuo, C-H, Rush, G.F. and Hook, J.B., Renal cortical accumulation of phenobarbital in rats and rabbits: lack of correlation with induction of renal microsomal mono-oxygenases, J. Pharmacol. Exp. Ther., 220, 547, 1982.
Fowler, B.A., Hook, G.E.R. and Lucier, G.W., Tetrachlorodibenzo-p-dioxin induction of renal microsomal enzyme systems. Ultrastructural effects on pars recta (S3) proximal tubule cells of the rat kidney, J. Pharmacol. Exp. Ther., 203, 712, 1977.
Rush, G.F., Wilson, D.M. and Hook, J.B., Selective induction of renal mixed function oxidases in the rat and rabbit, Fundam. Appi. Toxicol., 3, 161, 1983.
Zenser, T.V., Mattammal, M.B. and Davis, B.B., Differential distribution of the mixed function oxidase activities in rabbit kidney, J. Pharmacol. Exp. Ther., 207, 719, 1978
Endou, H., Cytochrome P-450 monoxygenase system in the rabbit kidney, its intranephron localisation and its induction, Japan. J. Pharmacol., 33, 423, 1983.
Rush, G.F., Maita, K. Sleight, S.D. and Hook, J.B., Induction of rabbit renal mixed-function oxidases by phenobarbital: cell specific ultrastruc- tural changes in the proximal tubule, Proc. S.c. Exp. Biol. Med., 172, 430, 1983.
Pratt, I.S., Lock, E.A., Hook, J.B. and Rush, G.F., Effects of the mono- oxygenase inducers polybrominated biphenyl and a-naphthoflavone on renal morphology and biochemistry in rats and mice, in Renal Heterogeneity and Target Cell Toxicity, Bach, P.H. and Lock, E.A., Eds., J. Wiley, Chichester, 1985, 123.
Dees, J.H., Masters, B.S.S., Muller-Eberhard, U and Johnson, E.F., Effect of 2,3,7,8-tetrachlorodibenzo-p-dioxin and phenobarbitone on the occurrence and distribution of four cytochrome P-450 isoenzymes in rabbit kidney, Cancer Res., 42, 1423, 1982.
Ogita, K., Kusunose, E., Yamamoto, S., Ichihara, K. and Kusunose, M., Multiple forms of cytochrome P-450 from kidney cortex microsomes of rabbits treated with phenobarbital, Biochem. Int., 6, 191, 1983.
Wolf, C.R., Hook, J.B. and Lock, E.A., Differential destruction of cytochrome P-450 dependent monooxygenases in rat and mouse kidney following hexachloro-1,3-butadiene administration, Mol. Pharmacol., 23, 206, 1983.
Onki, S., Ogino, N., Yamamoto, S. and Hayaishi, 0., Prostaglandin hydroperoxidase, an integral part of prostaglandin endoperoxide synthetase from bovine vesicular gland microsomes, J. Biol. Chem., 254, 829, 1979.
Zenser, T.V., Mattammal, M.B., Brown, W.W. and Davies, B.B., Cooxygenation by prostaglandin cyclooxygenase from rabbit inner medulla. Kidney Int., 16, 688, 1979.
Zenser, T.V., Mattammal, M.B. and Davis, B.B., Cooxidation of benzidine by renal medullary prostaglandin cyclooxygenase, J. Pharmacol. Exp. Ther., 211, 460, 1979.
Mattammal, M.B., Zenser, T.V., Brown, W.W., Herman, C.A. and Davis, B.B., Mechanism of inhibition of renal prostaglandin production by acetaminophen, J. Pharmacol. Exp. Ther., 210, 405, 1979.
Marnett, L.J. Wlodawer, P. and Samuelsson, B., Co-oxidation of organic substrates by the prostaglandin synthetase of sheep vesicular gland, J. Biol. Chem., 250, 8510, 1975.
Marnett, L.J., Bienkowski, M.J. and Pagels, W.R., Oxygen 18 investigations of the prostaglandin synthetase-dependent co-oxidation of diphenylisoben- zofuran, J. Biol. Chem., 254, 5077, 1979.
Zenser, T.V., Mattammal, M.B. and Davis, B.B., Demonstration of separate pathways for the metabolism of organic compounds in rabbit kidney, J. Pharmacol. Exp. Ther., 208, 418, 1979.
Smith, W.L. and Bell, T.G., Immunohistochemical localisation of the prostaglandin-formed cyclooxygenase in renal cortex, Am. J. Physiol., 235, F451, 1978.
Marnett, L.J. and Eling, T.E., Cooxidation during prostaglandin biosynthesis: a pathway for the metabolic activation of xenobiotics, in Reviews in Biochemical Toxicology Vol. 5, Hodgson, E., Bend, J.R. and Phil- pot, R.M., Eds., Elsevier, New York, 1983, 135.
Boyd, J.A. and Eling, T.E., Prostaglandin endoperoxide synthetase-dependent co-oxidation of acetaminophen to intermediates which covalently bind in vitro to rabbit renal medullary microsomes, J. Pharmacol. Exp. Ther., 219, 659, 1981.
Mohandes, J., Duggin, G.G., Horvath, J.S. and Tiller, D.J., Metabolic oxidation of acetaminophen (paracetamol) mediated by cytochrome P-450 mixed function oxidase and prostaglandin endoperoxide synthase in rabbit kidney, Toxicol. Appl. Pharmacol., 61, 552, 1981.
Moldeus, P. and Rahimtula, A., Metabolism of paracetamol to a glutathione conjugate catalysed by prostaglandin synthetase, Biochem. Biophys. Res. Com- mun., 96, 469, 1980.
Livesey, J.C. and Anders, M.W., In vitro metabolism of 1,2-dihaloethanes to ethylene, Drug. Metab. Dispos., 7, 199, 1979.
Hill, D.L., Shih, T.W., Johnston, T.P. and Struck, R.F., Macromolecular binding and metabolism of the carcinogen 1,2-dibromoethane, Cancer Res., 38, 2438, 1978.
Van Bladeren, P.J., Breimer, D.D., Rotteveel-Smijs, G.M.T., De Jong, R.A.W., Buijs, W., Van Der Gen, A. and Mohn, G.R., The role of glutathione conjugation in the mutagenicity of 1,2-dibromoethane, Biochem. Pharmacol., 29, 2975, 1980.
Schasteen, C.S. and Reed, D.J., The hydrolysis and alkylation activities of S-(2-haloethyl)-L-cysteine analogs - evidence for extended half-life, Toxicol. Appl. Pharmacol., 70, 423, 1983.
Elfarra, A.A., Baggs, R.B. and Anders, M.W., Structure-nephrotoxicity relationships of S-(2-chloroethyl)-DL-cysteine and analogs: role for an episulphonium ion, J. Pharmacol. Exp. Ther., 233, 512, 1985.
Lock, E.A. and Green, T., Selective activation of chemicals by the kidney: its relevance to toxicity and mutagenicity, in Proceeding 9th International Congress of Pharmacology, Vol. 1, Paton, W., Mitchell, J. and Turner, P., Eds., Macmillan, London, 1984, 197.
Nash, J.A., King, L.J., Lock, E.A. and Green T., The metabolism and disposition of hexachloro-1,3-butadiene in the rat and its relevance to nephrotoxicity, Toxicol. Appl. Pharmacol., 73, 124, 1984.
Gandolfi, A.J., Nagle, R.B., Soltis, J.J. and Plescia, F.H., Nephrotoxicity of halogenated vinyl cysteine compounds, Res. Corrm. Pathol. Pharmacol., 33 249, 1981.
Odum, J. and Green T., The metabolism and nephrotoxicity of tetrafluoroethylene in the rat, Toxicol. Appl. Pharmacol., 76, 306, 1984.
Rannug, U., Sundvall, A. and Ramel, C., The mutagenic effect of 1,2- dichloroethane on Salmonella typhimurium I. Activation through conjugation with glutathione in vitro, Chem-Biol. Interact., 20, 1, 1978.
Van Bladeren, P.J., Breimer, D.D., Rotteveel-Smijs, G.M.T., De Knijff, P., Mohn, G.R., Van Meeteren-Walchi, B., Buijs, W. and Van Der Gen, A., The relation between the structure of vicinal dihalogen compounds and their mutagenic activation via conjugation to glutathione, Carcinogenesis, 2, 499, 1981.
Guengerich, F.P., Crawford, W.M., Domoradzki, J.Y., Macdonald, T.L. and Watanabe, P.G., In vitro activation of 1,2-dichloroethane by microsomal and cytosolic enzymes, Toxicol. Appl. Pharmacol., 55, 303, 1980.
Inskeep, P.B. and Guengerich, F.P., Glutathione-mediated binding of dibromoalkanes to DNA: specificity of rat glutathione-S-transferases and dibromoalkane structure, Carcinogenesis, 5, 805, 1984.
Morganstern, R., Guthenberg, C. and De Pierre, J.W., Microsomal glutathione S-transferase, Eur. J. Biochem., 128, 243, 1982.
Ross, B.D. and Guder, W.G., Heterogeneity and compartment at ion in the kidney, in Metabolic Compartmentation, Sies, H., Ed., Academic Press, London- New York, 1982, 363.
Dohn, D.R. and Anders, M.W., The enzymatic reaction of chlorotri- fluoroethylene with glutathione, Biochem. Biophys. Res. Commun., 109, 1339, 1982.
Wolf, C.R., Berry, P.N., Nash, J.A., Green, T. and Lock, E.A., The role of microsomal and cytosolic glutathione-S-transferases in the conjugation of hexachloro-1,3-butadiene and its possible relevance to toxicity, J. Pharmacol. Exp. Ther., 228, 202, 1984.
Oesch, F. and Wolf, C.R., Properties of the microsomal glutathione transferases involved in hexachlorobutadiene and chloro-2,4-dinitrobenzene conjugation, Mol. Pharmacol., in press.
Gerdes, R.G., Jones, T.W., Ormstad, K and Orrenius, S., The formation of glutathione conjugates of hexachlorobutadiene by isolated liver cells, in Renal Heterogeneity and Target Cell Toxicity, Bach, P.H. and Lock E.A., Eds., J. Wiley, Chichester, 1985, 145.
Bhattacharya, R.K. and Schultze, M.O., Enzymes in bovine and turkey kidneys which cleave S-(l,2-dichlorovinyl)-L-cysteine, Comp. Biochem. Physiol., 22, 723, 1967.
Anderson, P.M. and Schultze, M.O., Cleavage of S-(l,2-dichlorovinyl)-L- cysteine by an enzyme of bovine origin, Arch. Biochem. Biophys., Ill, 593, 1965.
Stonard, M.D. and Parker, V.H., Metabolism of S-(l,2-dichlorovinyl)-L- cysteine by rat liver mitochondria, Biochem. Pharmacol., 20, 2429, 1971.
Stevens, J.L., Cysteine conjugate p-lyase activities in rat kidney cortex: subcellular localisation and relationship to the hepatic enzyme, Biochem. Biophys. Res. Commun., 129, 499, 1985.
Tateishi, M., Suzuki, S. and Shimizu, H., Cysteine conjugate (S-lyase in rat liver, J. Biol. Chem., 253, 8854, 1978.
Stevens, J. and Jakoby, W.B., Cysteine conjugate p-lyase, Mol. Pharmacol., 23, 761, 1983.
Dohn, D.R. and Anders, M.W., A simple assay for cysteine conjugate 0-lyase activity with S-(2-benzothiazolyl) cysteine as the substrate, Anal. Biochem., 120, 379, 1982.
Stevens, J.L., Isolation and characterisation of a rat liver enzyme with both cysteine conjugate p-lyase and kynureninase activity, J. Biol. Chem., 260, 7945, 1985.
Tateishi, M. and Shimizu, H., Cysteine conjugate p-lyase, in Enzymatic Basis of Detoxication Vol. 2, Jakoby, W.B., Ed., Academic Press, New York, 1980, 121.
Lock, E.A., and Ishmael, J., Effect of the organic acid transport inhibitor probenecid on renal cortical uptake and proximal tubular toxicity of hexachloro-1,3-butadiene and its conjugates, Toxicol. Appl. Pharmacol, 81, 32, 1985.
Davidson, I.W.F., Sumner, D.D. and Parker, J.C., Chloroform: a review of its metabolism, teratogenic, mutagenic and carcinogenic potential, Drug Chem. Toxicol., 5, 1, 1982.
Pohl, L.R., Biochemical toxicology of chloroform, in Reviews in Biochemical Toxicology, Vol. 1, Hodgson, E., Bend, J.R. and Philpot, R.M., Eds., Elsevier, New York, 1979, 79.
Eschenbrenner, A.B., Induction of hepatomas in mice by repeated oral administration of chloroform with observations on sex differences, J. Natl. Cancer Inst., 5, 251, 1945.
Deringer, M.K., Dunn, T.B. and Heston, W.B., Results of exposure of strain C3H mice to chloroform, Proc. Soc. Exp. Biol. Med., 83, 474, 1953.
Shubik, P. and Ritchie, A.C., Sensitivity of male DBA mice to the toxicity of chloroform as a laboratory hazard, Science, 117, 285, 1953.
Hewitt, H.B., Renal necrosis in mice after accidental exposure to chloroform, Brit. J. Exp. Pathol., 37, 32, 1956.
Plaa, G.L. and Larson, R.E., Relative nephrotoxic properties of chlorinated methane, ethane and ethylene derivatives in mice, Toxicol. Appl. Pharmacol., 7, 37, 1965.
Kluwe, W.M. and Hook, J.B., Polybrominated biphenyl-induced potentiation of chloroform toxicity, Toxicol. Appl. Pharmacol., 45, 861, 1978.
Watrous, W.M. and Plaa, G.L., Effects of halogenated hydrocarbons on organic ion accumulation by renal cortical studies of rats and mice, Toxicol. Appl. Pharmacol., 22, 528, 1972.
Smith, J.H., Maita, K., Sleight, S.D. and Hook, J.B., Mechanism of chloroform toxicity, I. Time course of chloroform toxicity in male and female mice, Toxicol. Appl. Pharmacol., 70, 467, 1983.
Paul, B.B. and Rubinstein, D., Metabolism of carbon tetrachloride and chloroform by the rat, J. Pharmacol. Exp. Ther., 141, 141, 1963.
Smith, J.H. and Hook, J.B., Mechanism of chloroform toxicity. II. In vitro evidence for renal metabolism in mice, Toxicol. Appl. Pharmacol., 70, 480, 1983.
Ilett, K.F., Reid, W.D., Sipes, I.G. and Krishna, G., Chloroform toxicity in mice: correlation of renal and hepatic necrosis with covalent binding of metabolites to tissue macromolecules, Exp. Mol. Pathol., 19, 215, 1973.
Taylor, D.C., Brown, D.M., Keeble, R. and Langley, P.F., Metabolism of Chloroform. II. A sex difference in the metabolism of (C)-chloroform in mice, Xenobiotica, 4, 165, 1974.
Smith, J.H. and Hook, J.B., Mechanism of chloroform nephrotoxicity. III. Renal and hepatic microsomal metabolism of chloroform in mice, Toxicol. Appl. Pharmacol., 73, 511, 1984.
Branchflower, R.V., Nunn, D.S., Highet, R.J., Smith, J.H., Hook, J.B. and Pohl, L.R., Nephrotoxicity of chloroform: metabolism to phosgene by the mouse kidney, Toxicol. Appl. Pharmacol., 72, 159, 1984.
Pohl, L.R., George, J.W. and Satoh, H., Strain differences in chloroform induced nephrotoxicity: different rates of metabolism of chloroform to phosgene by the mouse kidney, Drug Metab. Dispos., 12, 304, 1984.
Kluwe, W.M. and Hook, J.B., Potentiation of acute chloroform nephrotoxicity by the glutathione depletor diethylmaleate and protection by the microsomal enzyme inhibitor piperonyl butoxide, Toxicol. Appl. Pharmacol., 59, 457, 1981.
Ahmadizadeh, M., Kuo, C.-H. and Hook, J.B., Nephrotoxicity and hepatotoxicity of chloroform in mice: effect of deuterium substitution, J. Toxicol., Environ. Health, 8, 105, 1981.
Bailie, M.B., Smith, J.H., Newton, J.F. and Hook, J.B., Mechanism of chloroform nephrotoxicity. IV. Phénobarbital potentiation of in vitro chloroform metabolism and toxicity in rabbit kidneys, Toxicol. Appl. Pharmacol., 74, 285, 1984.
Eschenbrenner, A.B. and Miller, E., Sex differences in kidney morphology and chloroform necrosis, Science, 102, 302, 1945.
Culliford, D, and Hewitt, H.B., The influence of sex hormone status on the susceptibility of mice to chloroform-induced necrosis of the renal tubules, J. Endocrinol, 14, 381, 1957.
Jacobsen, L., Anderson, E.K. and Thorbery, J.V., Accidental chloroform nephrosis in mice, Acta. Pathol. Microbiol. Scand., 61, 503, 1964.
Krus, S., Starzynski, S., Zaleska-Rutczynska, Z. and Naciazek-Wieniawska, A., The role of testosterone in developing chloroform-induced renal tubular necrosis in mice, Nephron, 12, 275, 1974.
Clemens, T.L., Hill, R.N., Bullock, L.P., Johnson, W.D., Sultatos, L.G. and Vesell, E.S., Chloroform toxicity in the mouse: role of genetic factors and steroids, Toxicol. Appi. Pharmacol., 48, 117, 1979.
Hill, R.N., Clemens, T.L., Liu, D.K., Vesell, E.S. and Johnson, W.D., Genetic control of chloroform toxicity in mice, Science, 190, 159, 1975.
Smith, J.H., Maita, K., Sleight, S.D. and Hook, J.B., Effect of sex hormone status on chloroform nephrotoxicity and renal mixed function oxidases in mice, Toxicology, 30, 305, 1984.
Rowe, V.K., Spencer, H.C., McCollister, D.D., Hollingsworth, R.L. and Adams, E.M., Toxicity of ethylene dibromide determined on experimental animals, Arch. Ind. Hyg. Occup. Med., 6, 158, 1952.
Spencer, H.C., Rowe, V.K., Adams, E.M., McCollister, D.D. and Irish, D.D., Vapour toxicity of ethylene dichloride determined by experiments on laboratory animals, Arch. Ind. Hyg. Occup. Med., 4, 482, 1951.
Olmstead, E.V., Pathological changes in ethylene dibromide poisoning, Arch. Ind. Health, 21, 525, 1960.
Weisburger, E.K., Carcinogenicity studies on halogenated hydrocarbons, Environ. Health Perspect., 21, 7, 1977.
Olson, W.A., Habermann, R.T. and Weisburger, E.K., Induction of stomach cancer in rats and mice by halogenated aliphatic fumigants, J. Natl. Cancer Inst., 51, 1993, 1972.
Wong, L.C.K., Winston, J.M., Hong, C.B. and Plotnick, H., Carcinogenicity and toxicity of 1,2-dibromoethane in the rat, Toxicol. Appi. Pharmacol., 63, 155, 1982.
National Cancer Institute, Technical background information report 55 on carcinogenesis bioassay of 1,2-dichloroethane (EDC), U.S. DHEW Publication (NIH), 78-136, Government Printing Office, Washington DC, 1978.
Johnson, M.K., The influence of some aliphatic compounds on rat liver glutathione levels, Biochem. Pharmacol., 14, 1383, 1965.
Nachtomi, E., Alumot, E. and Bondi, A., Biochemical changes in organs of chicks and rats poisoned with ethylene dibromide and carbon tetrachloride, Isr. J. Chem., 6, 803, 1968.
Kluwe, W.M., McNish, R., Smithson, K. and Hook, J.B., Depletion by 1,2- dibromoethane, l,2-dibromo-3-chloropropane, tris(2,3-dibromopropyl) phosphate and hexachloro-1,3 butadiene of reduced non-protein sulphydryl groups in target and nontarget organs, Biochem. Pharmacol., 30, 2265, 1981.
Nachtomi, E., Alumot, E. and Bondi, A., The metabolism of ethylene dibromide in the rat. I Identification of detoxication products in urine, Isr. J. Chem., 4, 239, 1966.
Nachtomi, E., The metabolism of ethylene dibromide in the rat: the enzymic reaction with glutathione in vitro and in vivo, Biochem. Pharmacol., 19, 2853, 1970.
Banerjee, S. and Van Duuren, B.L., Binding of carcinogenic halogenated hydrocarbons to cell macromolecules, J. Natl. Cancer. Inst., 63, 707, 1979.
Shih, T-W and Hill, D.L., Metabolic activation of 1,2-dibromoethane by glutathione transferase and by microsomal mixed function oxidase: further evidence for formation of two reactive metabolites, Res. Commun. Chem. Pathol. Pharmacol., 33, 449, 1981.
Sundheimer, D.W., White, R.D., Brendel, K. and Sipes, I.G., The bioactiva- tion of 1,2-dibromoethane in rat hepatocytes: covalent binding to nucleic acids, Carcinogenesis, 3, 1129, 1982.
Ozawa, N. and Guengerich, F.P, Evidence for formation of an S-[2-(N- guanyl)ethyl]glutathione adduct in glutathione-mediated binding of the carcinogen 1,2-dibromoethane to DNA, Proc. Natl. Acad. Sci., 80, 5266, 1983.
Vadi, H.V., Schasteen, C.S. and Reed, D.J., Interactions of S-(2-haloethyl) mercapturic acid analogs with plasmid DNA, Toxicol. Appi. Pharmacol., 80, 386, 1985.
Rannug, U. and Beije, B., The mutagenic effect of 1,2-dichloroethane on Salmonella typhimurium: II. Activation by the isolated perfused rat liver, Chem-Biol. Interact., 24, 265, 1979.
Gradiski, D., Duprat, P., Magadur, J-L. and Fayein, E., Etude toxicologique experimentale de l1hexachlorobutadiene, Eur. J. Toxicol., 8, 180, 1975.
Kociba, R.J., Schwetz, B.A., Keyes, D.G., Jersey, G.C., Ballard, J.J. Dit- tenber, D.A., Quast, J.F., Wade, C.E. and Humiston, C.G., Chronic toxicity and reproduction studies of hexachlorobutadiene in rats. Environ. Health Perspect., 21, 49, 1977.
Duprat, P. and Gradiski, D., Percutaneous toxicity of hexachlorobutadiene, Acta Pharmacol. Toxicol., 43, 346, 1978.
Harleman, J.H. and Seinen, W., Short-term toxicity and reproduction studies in rats with hexachloro-1,3-butadiene, Toxicol. Appi. Pharmacol., 47, 1, 1979.
Berndt, W.O. and Mehendale, H.M., Effects of hexachlorobutadiene (HCBD) on renal function and renal organic ion transport in the rat, Toxicology, 14, 55, 1979.
Lock, E.A. and Ishmael, J., The acute toxic effects of hexachloro-1,3- butadiene on the rat kidney, Arch. Toxicol., 43, 47, 1979.
Lock, E.A., Ishmael, J. and Pratt, I.S., Hydropic change in rat liver induced by hexachloro-1,3-butadiene, J. Appi. Toxicol., 2, 315, 1982.
Lock, E.A., Pratt, I.S. and Ishmael, J., Hexachloro-1,3-butadiene-induced hydropic change in mouse liver, J. Appi. Toxicol., 5, 74, 1985.
Ishmael, J., Pratt, I.S. and Lock, E.A., Necrosis of the pars recta (S3 segment) of the rat kidney produced by hexachloro-1,3-butadiene, J. Pathol., 138, 99, 1982.
Hook, J.B., Ishmael, J. and Lock E.A., Nephrotoxicity of hexachloro-1,3- butadiene in the rat: the effect of age, sex and strain, Toxicol. Appi. Pharmacol., 67, 121, 1983.
Lock, E.A., Ishmael, J. and Hook, J.B., Nephrotoxicity of hexachloro-1,3- butadiene in the mouse: the effect of age, sex, strain, monooxygenase modifiers, and the role of glutathione, Toxicol. Appi. Pharmacol., 72, 484, 1984.
Davis, M.E., Berndt, W.O. and Mehendale, H.M., Disposition and neph-rotoxicity of hexachloro-1,3-butadiene, Toxicology, 16, 179, 1980.
Hook, J.B., Rose, M.S. and Lock E.A., The nephrotoxicity of hexachloro-1,3- butadiene in the rat: studies of organic anion and cation transport in renal slices and the effect of monooxygenase inducers, Toxicol. Appi. Pharmacol., 65, 373, 1982.
Kociba, R.J., Keyes, D.G., Jersey, G.C., Ballard, J.J., Dittenber, D.A., Quast, J.F., Wade, C.E., Humiston, C.G. and Schwetz, B.A., Results of a two year chronic toxicity with hexachlorobutadiene in rats, Am. Ind. Hyg. Assoc. J., 38, 589, 1977.
Reichert, D., Schutz, S. and Metzler, M., Excretion pattern and metabolism of hexachlorobutadiene in rats: evidence for metabolic activation by conjugation reactions, Biochem. Pharmacol., 34, 399, 1985.
Lock, E.A. and Ishmael, J., Hepatic and renal non-protein sulphydryl concentration following toxic doses of hexachloro-1,3-butadiene in the rat: the effect of Arochlor 1254, phenobarbitone or SKF 525A treatment, Toxicol. Appi. Pharmacol., 57, 79, 1981.
Davis, M.E., Changes of hexachlorobutadiene nephrotoxicity after piperonyl butoxide treatment, Toxicology, 30, 217, 1984.
Davis, M.E., Berndt, W.O. and Mehendale, H.M., Diethylmaleate or cysteine pretreatment modifies hexachlorobutadiene nephrotoxicity, Toxicologist, 1, 9, 1981.
Bagget, J. McC. and Berndt, W.O., Renal and hepatic glutathione concentrations in rats after treatment with hexachloro-1,3-butadiene and citrinin, Arch. Toxicol., 56, 46, 1984.
Jaffe, D.R., Hassall, C.D., Brendel, K. and Gandolfi, A.J., In vivo and in vitro nephrotoxicity of the cysteine conjugate of hexachlorobutadiene, J. Toxicol. Environ. Health, 11, 857, 1983.
Nash, J.A., The metabolism and disposition of hexachloro-1,3-butadiene in the rat and its relevance to nephrotoxicity, M.Phil, thesis, University of Surrey, 1985.
Grafstrom, R., Ormstad, K., Moldeus, P. and Orrenius, S., Paracetamol metabolism in the isolated perfused rat liver with further metabolism of biliary conjugate by small intestines, Biochem. Pharmacol., 28, 3573, 1979.
Hirata, E. and Takahashi, H., Degradation of methyl mercury glutathione by the pancreatic enzymes in bile, Toxicol. Appl. Pharmacol., 58, 483, 1981.
Pratt, I.S., Ormond, T and Lock, E.A., Metabolism of the mercapturic acid of hexachloro-1,3-butadiene by rat kidney cytosol in vitro, Proc. 27th Congress Eur. Soc. Toxicol., Harrogate, UK., 27th-29th May 1986.
Green, T. and Odum J., Structure/activity studies of the nephrotoxic and mutagenic action of cysteine conjugates of chloro and fluoroalkenes, Chem.- Biol. Interact., 54, 15, 1985.
Moldeus, P., Andersson, B., Rahimtula, A. and Beggren, M., Prostaglandin synthetase catalysed activation of paracetamol, Biochem. Pharmacol., 31, 1363, 1982.
Nelson, S.D., Dahlin, D.C., Rauckman, E.J. and Rosen, G.M., Peroxidase- mediated formation of reactive metabolites of acetaminophen, Mol. Pharmacol., 20, 195, 1981.
Monks, T.J., Lau, S.S. and Gillette, J.R., Identification of 2- bromohydroquinone as a metabolite of bromobenzene, Pharmacologist, 25, 104, 1983.
Lau, S.S., Hubbard, W.C. and Monks, T.J., Metabolism of the nephrotoxin 2- bromohydroquinone by renal protaglandin synthetase, in Proceedings 6th International Symposium on Microsomes and Drug Oxidation, Brighton, S.ssex, U.K., 5-10 August 1984, 80.
Murray, G., Wyllie, R.G., Hill, G.S., Ramsen, P.W. and Heptinstall, R.H., Experimental papillary necrosis I. Morphologic and functional data, Am. J. Pathol., 67, 285, 1972.
Hill, G.S., Wyllie, R.G., Miller, M. and Heptinstall, R.H., Experimental papillary necrosis of the kidney. II. Electron microscopic and histochemical studies, Amer. J. Pathol., 68, 213, 1972.
Sabatini, S., Alia, V., Wilson, A., Cruz-Soto, M., De White, A., Kurtzman, N.A. and Arrunda, J.A.L., The effects of chronic papillary necrosis on acid secretion, Pflugers Arch., 393, 262, 1982.
Reid, W.D., Mechanism of renal necrosis induced by bromobenzene or chlorobenzene, Exp. Mol. Pathol., 19, 197, 1973.
Monks, T.J., Lau, S.S. and Gillette, J.R., Diffusion of reactive metabolites out of hepatocytes, in 8th European Workshop on Drug Metabolism, 1982, 113.
Lau, S.S., Monks, T., Greene, K.E. and Gillette, J.R., Detection of bromobenzene-3,4-oxide in blood, in 1st International Symposium on Foreign Compound Metabolism, 1983, 41.
Monks, T.J., Lau, S.S. and Gillete, J.R., A dual role of glutathione transferase in the detoxification of bromobenzene-3,4-oxide, Fed. Proc., 42, 1137, 1983.
Monks, T.J., Hinson, J.A. and Gillette, J.R., Bromobenzene and p-bromophenol toxicity and covalent binding in vivo, Life Sei., 30, 841, 1982.
Rush, G.F., Newton, J.F., Maita, K., Kuo, C.-H. and Hook, J.B., Neph-rotoxicity of phenolic bromobenzene metabolites in the mouse, Toxicology, 30, 259, 1984.
Lau, S.S., Monks, T.J., Greene, K.E. and Gillette, J.R., The role of ortho- bromophenol in the nephrotoxicity of bromobenzene in rats, Toxicol. Appl. Pharmacol., 72, 539, 1984.
Lau, S.S., Monks, T.J., Greene, K.E. and Gillette, J.R., Nephrotoxicity of o-bromophenol and 2-bromohydroquinone metabolites of bromobenzene in the rat, Pharmacologist, 25, 105, 1983.
Monks, T.J., Lau, S.S. and Gillette, J.R., Glutathione conjugates of 2- bromohydroquinone, a metabolite of bromobenzene are nephrotoxic, in 1st International Symposium on Foreign Compound Metabolism, 1983, 48.
Monks, T.J., Lau, S.S. and Gillette, J.R., The metabolism and nephrotoxicity of 2-bromohydroquinone glutathione conjugates, in 6th International Symposium on Microsomes and Drug Oxidation, Brighton, Sussex, U.K., 5-10 August 1984, 23.
Terracini, B. and Parker, V.H., A pathological study on the toxicity of S- Dichlorovinyl-L-cysteine, Fd. Cosmet. Toxicol., 3, 67, 1965.
Lock, E.A., Odum, J. and Ormond, P., Transport of N-acetyl-S-pentachloro- 1,3-butadienyIcysteine by rat renal cortex, Arch. Toxicol., 15, 12, 1986.
Hassall, C.D., Gandolfi, A.J. and Brendel, K., Effect of halogenated vinyl cysteine conjugates on renal tubular active transport, Toxicology, 26, 285, 1983.
Hassall, C.D., Gandolfi, A.J., Duhamel, R.C. and Brendel K., The formation and biotransformation of cysteine conjugates of halogenated ethylenes by rabbit renal tubules., Chem.-Biol. Interact., 49, 283, 1984.
Earl, L.K., McLean, A.E.M. and Lock, E.A., Use of isolated kidney cells for studying nephrotoxicity: hexachloro-1,3-butadiene as a model compound, Human Toxicol., 3, 332, 1984.
Lash, L.H. and Jones, D.P., Uptake of the glutathione conjugate S-(l,2- dichlorovinyl)glutathione by renal basal-lateral membrane vesicles and isolated kidney cells, Mol. Pharmacol., 28, 278, 1985.
Elfarra, A.A. and Anders, M.W., Renal processing of glutathione conjugates: role in nephrotoxicity, Biochem. Pharmacol., 33, 3729, 1984.
Parker, V.H., A biochemical study of the toxicity of S-dichlorovinyl-L- cysteine, Fd. Cosmet. Toxicol., 3, 75, 1965.
Stonard, M.D. and Parker, V.H., 2-oxoacid dehydrogenases of rat liver mitochondria as the site of action of S-(l,2-dichlorovinyl)-L-cysteine and S-(l,2-dichlorovinyl)-3-mercaptopropionic acid, Biochem. Pharmacol., 20, 2417, 1971.
Stonard, M.D., Further studies on the site and mechanism of action of S- (1,2-dichlorovinyl)-L-cysteine and S-(1,2-dichlorovinyl)-3-mercaptopropionic acid in rat liver, Biochem. Pharmacol., 22, 1329, 1973.
Schnellmann, R.G., Lock, E.A. and Mandel, L.J., A mechanism of S-(l,l,2,3,4- pentachloro-1,3-butadienyl)-L-cysteine (PCBC) toxicity to rabbit proximal tubules (RPT), Toxicologist, 6, 176, 1986.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1987 Martinus Nijhoff Publishers
About this chapter
Cite this chapter
Lock, E.A. (1987). Metabolic Activation of Halogenated Chemicals and its Relevance to Nephrotoxicity. In: Bach, P.H., Lock, E.A. (eds) Nephrotoxicity in the experimental and clinical situation. Developments in Nephrology, vol 19-20. Springer, Dordrecht. https://doi.org/10.1007/978-94-009-3367-5_14
Download citation
DOI: https://doi.org/10.1007/978-94-009-3367-5_14
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-010-8012-5
Online ISBN: 978-94-009-3367-5
eBook Packages: Springer Book Archive